ArticleAnalytical chemistry2025
Exploring the Potential of Chemically Matched Fragments as Internal Standards for Quantitative SERS with Panobinostat.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-enhanced Raman spectroscopy (SERS) has great potential for therapeutic drug monitoring (TDM) due to its high sensitivity; however, achieving accurate and robust quantitative data remains challenging. The most effective approach for quantitative SERS is to use internal standards (IS). Isotopologues are particularly effective; however, these or closely related analogues of the target compound are often unavailable. We have addressed this problem by using fragments of the target compound as the IS. Here, 2-methylindole (2-MI) was identified as the most suitable fragment for Panobinostat (Pano). Tests with an enhancing colloid that degraded significantly over a 4-week period showed that the 2-MI IS allowed changes in the absolute intensity of the Pano signal over time to be corrected and that the standard error achieved with the degrading enhancing medium matched that of results obtained with the fresh colloid. The calibration range could be extended by using either low (4 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.